Intellectual Property

© GettyImages/Tanaonte

Guest Article

What does Brexit mean for biopharma companies?

By Mike Pears and Joel Beevers, Patent Attorneys at Potter Clarkson

January 1, 2021 marked the UK’s official separation from the EU and with that has come a raft of changes to how the nation will now do business with the rest of the world.

(Image: Getty/Ronniechua)

How the US-Mexico trade deal could impact the biologics market

By Ben Hargreaves

BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lione’s biopharma practice group, the provisional detail revealed from the US administration’s proposed trade deal with Mexico, and its potential impact on the...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers